{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:39:12Z","timestamp":1784885952813,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["0315477B"],"award-info":[{"award-number":["0315477B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Verein zur F\u00f6rderung der Krebsmedizin - Kirstins Weg e.V."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12944-017-0495-5","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T08:20:30Z","timestamp":1496391630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5979-5982","authenticated-orcid":false,"given":"Kristin","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"K\u00fcllenberg de Gaudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Keck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich T.","family":"Hopt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Massing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,2]]},"reference":[{"key":"495_CR1","first-page":"88","volume":"5","author":"CR Tan","year":"2014","unstructured":"Tan CR, et al. Pancreatic cancer cachexia: a review of mechanisms and therapeutics. Front Physiol. 2014;5:88.","journal-title":"Front Physiol"},{"key":"495_CR2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/1098-1128(200101)21:1<83::AID-MED4>3.0.CO;2-1","volume":"21","author":"JM Argiles","year":"2001","unstructured":"Argiles JM, Meijsing SH, Pallares-Trujillo J, Guirao X, Lopez-Soriano FJ. Cancer cachexia: a therapeutic approach. Med res rev. 2001;21:83\u2013101.","journal-title":"Med res rev"},{"key":"495_CR3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clnu.2003.07.001","volume":"23","author":"W Davidson","year":"2004","unstructured":"Davidson W, Ash S, Capra S, Bauer J. Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr. 2004;23:239\u201347.","journal-title":"Clin Nutr"},{"key":"495_CR4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc927","volume":"2","author":"MJ Tisdale","year":"2002","unstructured":"Tisdale MJ. Cachexia in cancer patients. Nat rev Cancer. 2002;2:862\u201371.","journal-title":"Nat rev Cancer"},{"key":"495_CR5","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjc.6601620","volume":"90","author":"AW Moses","year":"2004","unstructured":"Moses AW, Slater C, Preston T, Barber MD, Fearon KC. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer. 2004;90:996\u20131002.","journal-title":"Br J Cancer"},{"key":"495_CR6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/bmj.309.6953.544","volume":"309","author":"SJ Wigmore","year":"1994","unstructured":"Wigmore SJ, Falconer JS, Fearon KC. Fatty acids for treating pancreatic cancer. Bmj. 1994;309:544.","journal-title":"Bmj"},{"key":"495_CR7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","volume":"55","author":"D Wang","year":"2006","unstructured":"Wang D, Dubois RN. Prostaglandins and cancer. Gut. 2006;55:115\u201322.","journal-title":"Gut"},{"key":"495_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00520-009-0640-4","volume":"18","author":"LA Taylor","year":"2010","unstructured":"Taylor LA, Pletschen L, Arends J, Unger C, Massing U. Marine phospholipids--a promising new dietary approach to tumor-associated weight loss. Support Care Cancer. 2010;18:159\u201370.","journal-title":"Support Care Cancer"},{"key":"495_CR9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198902023200501","volume":"320","author":"S Endres","year":"1989","unstructured":"Endres S, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J med. 1989;320:265\u201371.","journal-title":"N Engl J med"},{"key":"495_CR10","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2353\/ajpath.2010.100322","volume":"177","author":"CN Serhan","year":"2010","unstructured":"Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol. 2010;177:1576\u201391.","journal-title":"Am J Pathol"},{"key":"495_CR11","unstructured":"Wigmore, S. J., Fearon, K. C., Maingay, J. P. & Ross, J. A. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci (London, Engl. 1979) 92, 215\u2013221 (1997)."},{"key":"495_CR12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1017\/S000711450765795X","volume":"97","author":"R Colomer","year":"2007","unstructured":"Colomer R, et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr. 2007;97:823\u201331.","journal-title":"Br J Nutr"},{"key":"495_CR13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.bjc.6690654","volume":"81","author":"MD Barber","year":"1999","unstructured":"Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999;81:80\u20136.","journal-title":"Br J Cancer"},{"key":"495_CR14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1207\/S15327914NC3602_6","volume":"36","author":"SJ Wigmore","year":"2000","unstructured":"Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer. 2000;36:177\u201384.","journal-title":"Nutr Cancer"},{"key":"495_CR15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/SLA.0b013e31819a4789","volume":"249","author":"AM Ryan","year":"2009","unstructured":"Ryan AM, et al. Enteral nutrition enriched with eicosapentaenoic acid ({EPA)} preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg. 2009;249:355\u201363.","journal-title":"Ann Surg"},{"key":"495_CR16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hed.21580","volume":"33","author":"HG Weed","year":"2011","unstructured":"Weed HG, et al. Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein- and energy-dense nutritional supplement containing eicosapentaenoic acid. Head Neck. 2011;33:1027\u201333.","journal-title":"Head Neck"},{"key":"495_CR17","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/bjc.2011.391","volume":"105","author":"RA Murphy","year":"2011","unstructured":"Murphy RA, Yeung E, Mazurak VC, Mourtzakis M. Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia. Br J Cancer. 2011;105:1469\u201373.","journal-title":"Br J Cancer"},{"key":"495_CR18","first-page":"1385","volume":"26","author":"C G\u00f3mez-Candela","year":"2011","unstructured":"G\u00f3mez-Candela C, et al. Efficacy evaluation of an oral powder supplement enriched with eicosapentaenoic acid in cancer patients. Nutr Hosp Organo of la soc Espa\u00f1ola Nutr Parenter y Enter. 2011;26:1385\u201393.","journal-title":"Nutr Hosp Organo of la soc Espa\u00f1ola Nutr Parenter y Enter"},{"key":"495_CR19","doi-asserted-by":"crossref","unstructured":"van der Meij BS, et al. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage {III} non-small cell lung cancer during multimodality treatment. J Nutr. 1774\u20131780;140","DOI":"10.3945\/jn.110.121202"},{"key":"495_CR20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1200\/JCO.2003.01.101","volume":"21","author":"E Bruera","year":"2003","unstructured":"Bruera E, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia\/cachexia: a double-blind, placebo-controlled study. J Clin Oncol Off J am soc Clin Oncol. 2003;21:129\u201334.","journal-title":"J Clin Oncol Off J am soc Clin Oncol"},{"key":"495_CR21","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/gut.52.10.1479","volume":"52","author":"KC Fearon","year":"2003","unstructured":"Fearon KC, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003;52:1479\u201386.","journal-title":"Gut"},{"key":"495_CR22","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","volume":"24","author":"KC Fearon","year":"2006","unstructured":"Fearon KC, et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol. 2006;24:3401\u20137.","journal-title":"J Clin Oncol"},{"key":"495_CR23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/cncr.20362","volume":"101","author":"CP Burns","year":"2004","unstructured":"Burns CP, et al. Phase {II} study of high-dose fish oil capsules for patients with cancer-related cachexia. Cancer. 2004;101:370\u20138.","journal-title":"Cancer"},{"key":"495_CR24","first-page":"3942","volume":"5","author":"CP Burns","year":"1999","unstructured":"Burns CP, et al. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer res. 1999;5:3942\u20137.","journal-title":"Clin Cancer res"},{"key":"495_CR25","first-page":"875","volume":"45","author":"K Oette","year":"1995","unstructured":"Oette K, et al. Absorption of di-linoleoylphosphatidylcholine after oral administration. Arzneimittelforschung. 1995;45:875\u20139.","journal-title":"Arzneimittelforschung"},{"key":"495_CR26","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0022-2275(20)38050-0","volume":"23","author":"O Zierenberg","year":"1982","unstructured":"Zierenberg O, Grundy SM. Intestinal absorption of polyenephosphatidylcholine in man. J Lipid res. 1982;23:1136\u201342.","journal-title":"J Lipid res"},{"key":"495_CR27","doi-asserted-by":"crossref","first-page":"15401","DOI":"10.3390\/ijms131115401","volume":"13","author":"L Burri","year":"2012","unstructured":"Burri L, Hoem N, Banni S, Berge K. Marine omega-3 phospholipids: metabolism and biological activities. Int J Mol Sci. 2012;13:15401\u201319.","journal-title":"Int J Mol Sci"},{"key":"495_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1476-511X-10-145","volume":"10","author":"JP Schuchardt","year":"2011","unstructured":"Schuchardt JP, et al. Incorporation of {EPA} and {DHA} into plasma phospholipids in response to different omega-3 fatty acid formulations - a comparative bioavailability study of fish oil vs. krill oil. Lipids Health Dis. 2011;10:145.","journal-title":"Lipids Health Dis"},{"key":"495_CR29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1476-511X-12-178","volume":"12","author":"VR Ramprasath","year":"2013","unstructured":"Ramprasath VR, Eyal I, Zchut S, Jones PJH. Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil. Lipids Health Dis. 2013;12:178.","journal-title":"Lipids Health Dis"},{"key":"495_CR30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11745-010-3490-4","volume":"46","author":"SM Ulven","year":"2011","unstructured":"Ulven SM, et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of {EPA} and {DHA}, in healthy volunteers. Lipids. 2011;46:37\u201346.","journal-title":"Lipids"},{"key":"495_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1079\/BJN19740060","volume":"32","author":"JV Durnin","year":"1974","unstructured":"Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;32:77\u201397.","journal-title":"Br J Nutr"},{"key":"495_CR32","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jn\/129.6.1120","volume":"129","author":"MD Barber","year":"1999","unstructured":"Barber MD, Ross JA, Preston T, Shenkin A, Fearon KC. Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr. 1999;129:1120\u20135.","journal-title":"J Nutr"},{"key":"495_CR33","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3945\/jn.110.121202","volume":"140","author":"BS Meij van der","year":"2010","unstructured":"van der Meij BS, et al. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage {III} non-small cell lung cancer during multimodality treatment. J Nutr. 2010;140:1774\u201380.","journal-title":"J Nutr"},{"key":"495_CR34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1207\/S15327914NC402_7","volume":"40","author":"MD Barber","year":"2001","unstructured":"Barber MD, Fearon KC, Tisdale MJ, McMillan DC, Ross JA. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer. 2001;40:118\u201324.","journal-title":"Nutr Cancer"},{"key":"495_CR35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/cs0980389","volume":"98","author":"MD Barber","year":"2000","unstructured":"Barber MD, McMillan DC, Preston T, Ross JA, Fearon KC. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci. 2000;98:389\u201399.","journal-title":"Clin Sci"},{"key":"495_CR36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nut.2004.05.026","volume":"21","author":"C Persson","year":"2005","unstructured":"Persson C, Glimelius B, R\u00f6nnelid J, Nygren P. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study. Nutrition. 2005;21:170\u20138.","journal-title":"Nutrition"},{"key":"495_CR37","first-page":"286","volume":"16","author":"CC Tanchoco","year":"2007","unstructured":"Tanchoco CC, et al. Diet supplemented with MCT oil in the management of childhood diarrhea. Asia Pac J Clin Nutr. 2007;16:286\u201392.","journal-title":"Asia Pac J Clin Nutr"},{"key":"495_CR38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00000658-199302000-00012","volume":"217","author":"ZM Jiang","year":"1993","unstructured":"Jiang ZM, et al. A comparison of medium-chain and long-chain triglycerides in surgical patients. Ann Surg. 1993;217:175\u201384.","journal-title":"Ann Surg"},{"key":"495_CR39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/bjc.1987.149","volume":"56","author":"MJ Tisdale","year":"1987","unstructured":"Tisdale MJ, Brennan RA, Fearon KC. Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer. 1987;56:39\u201343.","journal-title":"Br J Cancer"},{"key":"495_CR40","first-page":"557","volume":"88","author":"K Widhalm","year":"1976","unstructured":"Widhalm K, G\u00f6tz M. Long-term use of medium chain triglycerides in cystic fibrosis (author\u2019s transl). Wien Klin Wochenschr. 1976;88:557\u201361.","journal-title":"Wien Klin Wochenschr"},{"key":"495_CR41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/gut.43.4.478","volume":"43","author":"PB Jeppesen","year":"1998","unstructured":"Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut. 1998;43:478\u201383.","journal-title":"Gut"},{"key":"495_CR42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/07315724.1994.10718369","volume":"13","author":"CA Gogos","year":"1994","unstructured":"Gogos CA, Zoumbos N, Makri M, Kalfarentzos F. Medium- and long-chain triglycerides have different effects on the synthesis of tumor necrosis factor by human mononuclear cells in patients under total parenteral nutrition. J am Coll Nutr. 1994;13:40\u20134.","journal-title":"J am Coll Nutr"},{"key":"495_CR43","first-page":"476","volume":"149","author":"G Bounous","year":"1975","unstructured":"Bounous G, et al. Dietary protection during radiation therapy. Strahlentherapie. 1975;149:476\u201383.","journal-title":"Strahlentherapie"},{"key":"495_CR44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/bjc.1988.263","volume":"58","author":"MJ Tisdale","year":"1988","unstructured":"Tisdale MJ, Brennan RA. A comparison of long-chain triglycerides and medium-chain triglycerides on weight loss and tumour size in a cachexia model. Br J Cancer. 1988;58:580\u20133.","journal-title":"Br J Cancer"},{"key":"495_CR45","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1734-1140(11)70576-X","volume":"63","author":"K-J Gundermann","year":"2011","unstructured":"Gundermann K-J, Kuenker A, Kuntz E, Dro\u017adzik M. Activity of essential phospholipids (EPL) from soybean in liver diseases. Pharmacol rep. 2011;63:643\u201359.","journal-title":"Pharmacol rep"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-017-0495-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T02:30:37Z","timestamp":1659061837000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-017-0495-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["495"],"URL":"https:\/\/doi.org\/10.1186\/s12944-017-0495-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,2]]},"article-number":"104"}}